These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

221 related items for PubMed ID: 12482112

  • 1. Estrogen effects on neuroendocrine function: the new challenge of pulsed therapy.
    Genazzani AR, Bernardi F.
    Climacteric; 2002 Jun; 5 Suppl 2():50-6. PubMed ID: 12482112
    [Abstract] [Full Text] [Related]

  • 2. Pulsed estrogen therapy: relieving climacteric symptoms, preventing postmenopausal bone loss.
    Palacios S.
    Climacteric; 2002 Jun; 5 Suppl 2():32-9. PubMed ID: 12482109
    [Abstract] [Full Text] [Related]

  • 3. [Aerodiol: the efficacy and tolerability of intranasal estrogen administration. An overview].
    Genazzani AR, Cappagli B, Ciaponi M.
    Minerva Ginecol; 2003 Jun; 55(3):189-200. PubMed ID: 14581864
    [Abstract] [Full Text] [Related]

  • 4. Estrogen therapy: from women's choice to women's preference.
    Lachowsky M.
    Climacteric; 2002 Jun; 5 Suppl 2():46-9. PubMed ID: 12482111
    [Abstract] [Full Text] [Related]

  • 5. Safety and tolerability of pulsed estrogen therapy: key factors for an improved compliance.
    Mattsson LA.
    Climacteric; 2002 Jun; 5 Suppl 2():40-5. PubMed ID: 12482110
    [Abstract] [Full Text] [Related]

  • 6. Pulsed estrogen therapy: from cellular mode of action to tissue effects.
    Al-Azzawi F.
    Climacteric; 2002 Jun; 5 Suppl 2():27-31. PubMed ID: 12482108
    [Abstract] [Full Text] [Related]

  • 7. Hormone replacement therapy in the post-Women's Health Initiative era. Report a a meeting held in Funchal, Madeira, February 24-25, 2003.
    Burger H.
    Climacteric; 2003 May; 6 Suppl 1():11-36. PubMed ID: 12945798
    [Abstract] [Full Text] [Related]

  • 8. Influence of modified transdermal hormone replacement therapy on the concentrations of hormones, growth factors, and bone mineral density in women with osteopenia.
    Stanosz S, Zochowska E, Safranow K, Sieja K, Stanosz M.
    Metabolism; 2009 Jan; 58(1):1-7. PubMed ID: 19059524
    [Abstract] [Full Text] [Related]

  • 9. Vasoactive biomarkers and oxidative stress in healthy recently postmenopausal women treated with hormone replacement therapy.
    Maffei S, Mercuri A, Prontera C, Zucchelli GC, Vassalle C.
    Climacteric; 2006 Dec; 9(6):452-8. PubMed ID: 17085378
    [Abstract] [Full Text] [Related]

  • 10. Transdermal delivery of sex steroids for hormone replacement therapy and contraception. A review of principles and practice.
    Henzl MR, Loomba PK.
    J Reprod Med; 2003 Jul; 48(7):525-40. PubMed ID: 12953327
    [Abstract] [Full Text] [Related]

  • 11. The impact of different HRT regimens on compliance.
    Dören M, Schneider HP.
    Int J Fertil Menopausal Stud; 1996 Jul; 41(1):29-39. PubMed ID: 8673154
    [Abstract] [Full Text] [Related]

  • 12. Compliance to hormone replacement therapy.
    Rozenberg S, Vandromme J, Kroll M, Pastijn A, Liebens F.
    Int J Fertil Menopausal Stud; 1995 Jul; 40 Suppl 1():23-32. PubMed ID: 7581586
    [Abstract] [Full Text] [Related]

  • 13. Effects of postmenopausal hormone replacement therapy on body fat composition.
    Yüksel H, Odabasi AR, Demircan S, Köseoğlu K, Kizilkaya K, Onur E.
    Gynecol Endocrinol; 2007 Feb; 23(2):99-104. PubMed ID: 17454160
    [Abstract] [Full Text] [Related]

  • 14. Sex hormone replacement therapy and modulation of vascular function in cardiovascular disease.
    Koledova VV, Khalil RA.
    Expert Rev Cardiovasc Ther; 2007 Jul; 5(4):777-89. PubMed ID: 17605655
    [Abstract] [Full Text] [Related]

  • 15. Drospirenone in combination with estrogens: for contraception and hormone replacement therapy.
    Oelkers WH.
    Climacteric; 2005 Oct; 8 Suppl 3():19-27. PubMed ID: 16203652
    [Abstract] [Full Text] [Related]

  • 16. Quality of life assessment in a chemoprevention trial: fenretinide and oral or transdermal HRT.
    Serrano D, Mariani L, Mora S, Guerrieri-Gonzaga A, Cazzaniga M, Daldoss C, Ramazzotto F, Feroce I, Decensi A, Bonanni B.
    Maturitas; 2006 Aug 20; 55(1):69-75. PubMed ID: 16500052
    [Abstract] [Full Text] [Related]

  • 17. Added benefits of drospirenone for compliance.
    Foidart JM.
    Climacteric; 2005 Oct 20; 8 Suppl 3():28-34. PubMed ID: 16203653
    [Abstract] [Full Text] [Related]

  • 18.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 19. Two routes of hormonal replacement therapy in symptomatic menopausal women after kidney transplantation.
    Pietrzak B, Wielgos M, Kaminski P, Bobrowska K.
    Neuro Endocrinol Lett; 2006 Jun 20; 27(3):387-91. PubMed ID: 16816826
    [Abstract] [Full Text] [Related]

  • 20. Estrogen replacement therapy and the estraderm transdermal system.
    Youngkin EQ.
    Nurse Pract; 1990 May 20; 15(5):19-26, 31. PubMed ID: 2342664
    [Abstract] [Full Text] [Related]

    Page: [Next] [New Search]
    of 12.